MARX Biotech Statistics

Total Valuation

MARX Biotech has a market cap or net worth of TWD 3.50 billion. The enterprise value is 3.41 billion.

Market Cap	3.50B
Enterprise Value	3.41B

Important Dates

The next estimated earnings date is Friday, April 25, 2025.

Earnings Date	Apr 25, 2025
Ex-Dividend Date	n/a

Share Statistics

MARX Biotech has 498.06 million shares outstanding. The number of shares has increased by 33.97% in one year.

Current Share Class	n/a
Shares Outstanding	498.06M
Shares Change (YoY)	+33.97%
Shares Change (QoQ)	+4.63%
Owned by Insiders (%)	23.59%
Owned by Institutions (%)	n/a
Float	300.99M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	7.71
PB Ratio	14.22
P/TBV Ratio	16.56
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-51.15
EV / Sales	7.68
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-48.47

Financial Position

The company has a current ratio of 2.13, with a Debt / Equity ratio of 0.03.

Current Ratio	2.13
Quick Ratio	1.41
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	-0.11
Interest Coverage	-207.44

Financial Efficiency

Return on equity (ROE) is -33.66% and return on invested capital (ROIC) is -19.72%.

Return on Equity (ROE)	-33.66%
Return on Assets (ROA)	-13.43%
Return on Invested Capital (ROIC)	-19.72%
Return on Capital Employed (ROCE)	-26.43%
Revenue Per Employee	5.55M
Profits Per Employee	-833,687
Employee Count	80
Asset Turnover	1.45
Inventory Turnover	2.00

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -36.09% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-36.09%
50-Day Moving Average	7.44
200-Day Moving Average	8.47
Relative Strength Index (RSI)	35.72
Average Volume (20 Days)	1,402,118

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MARX Biotech had revenue of TWD 444.16 million and -66.70 million in losses. Loss per share was -0.14.

Revenue	444.16M
Gross Profit	327.72M
Operating Income	-65.76M
Pretax Income	-68.89M
Net Income	-66.70M
EBITDA	-58.96M
EBIT	-65.76M
Loss Per Share	-0.14

Full Income Statement

Balance Sheet

The company has 97.96 million in cash and 7.74 million in debt, giving a net cash position of 90.22 million or 0.18 per share.

Cash & Cash Equivalents	97.96M
Total Debt	7.74M
Net Cash	90.22M
Net Cash Per Share	0.18
Equity (Book Value)	246.24M
Book Value Per Share	0.49
Working Capital	185.71M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -67.25 million and capital expenditures -3.14 million, giving a free cash flow of -70.38 million.

Operating Cash Flow	-67.25M
Capital Expenditures	-3.14M
Free Cash Flow	-70.38M
FCF Per Share	-0.14

Full Cash Flow Statement

Margins

Gross margin is 73.78%, with operating and profit margins of -14.80% and -15.02%.

Gross Margin	73.78%
Operating Margin	-14.80%
Pretax Margin	-15.51%
Profit Margin	-15.02%
EBITDA Margin	-13.27%
EBIT Margin	-14.80%
FCF Margin	n/a

Dividends & Yields

MARX Biotech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-33.97%
Shareholder Yield	-33.97%
Earnings Yield	-1.90%
FCF Yield	-2.01%

Stock Splits

The last stock split was on July 11, 2024. It was a forward split with a ratio of 2.

Last Split Date	Jul 11, 2024
Split Type	Forward
Split Ratio	2

Scores

MARX Biotech has an Altman Z-Score of 12.09.

Altman Z-Score	12.09
Piotroski F-Score	n/a